William Blair & Company
CLOV icon

William Blair & Company’s Clover Health Investments CLOV Stock Holding History

William Blair & Company’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$501K Buy
95,624
+831
+0.9% +$2.82K ﹤0.01% 1231
2026
Q1 		$167K Buy
94,793
+15,293
+19% +$33.2K ﹤0.01% 1515
2025
Q4 		$187K Hold
79,500
– – ﹤0.01% 1480
2025
Q3 		$243K Buy
79,500
+28,000
+54% +$80K ﹤0.01% 1389
2025
Q2 		$144K Buy
51,500
+25,000
+94% +$82.2K ﹤0.01% 1471
2025
Q1 		$95.1K Buy
+26,500
New +$106K ﹤0.01% 1503
2023
Q4 		– Sell
-17,350
Closed -$18.7K – 1797
2023
Q3 		$18.7K Sell
17,350
-11,821
-41% -$14.1K ﹤0.01% 1682
2023
Q2 		$26.2K Sell
29,171
-28,579
-49% -$25.4K ﹤0.01% 1672
2023
Q1 		$48.8K Sell
57,750
-34,000
-37% -$37.2K ﹤0.01% 1584
2022
Q4 		$85.3K Sell
91,750
-8,850
-9% -$11.8K ﹤0.01% 1509
2022
Q3 		$171K Sell
100,600
-565
-0.6% -$1.48K ﹤0.01% 1418
2022
Q2 		$216K Sell
101,165
-263
-0.3% -$699 ﹤0.01% 1384
2022
Q1 		$360K Sell
101,428
-500
-0.5% -$1.45K ﹤0.01% 1290
2021
Q4 		$379K Sell
101,928
-103,153
-50% -$633K ﹤0.01% 1317
2021
Q3 		$1.52M Sell
205,081
-13,719
-6% -$117K 0.01% 772
2021
Q2 		$2.91M Buy
218,800
+20,213
+10% +$199K 0.01% 594
2021
Q1 		$1.5M Buy
+198,587
New +$2.24M 0.01% 774

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

William Blair & Company's CLOV Position: Q2 2026 in Review

William Blair & Company increased its Clover Health Investments (CLOV) stake by 0.88% in Q2 2026, buying an estimated $2.82K and bringing the position to 95,624 shares worth $501K. The position accounts for ﹤0.01% of the portfolio, ranked #1231.

William Blair & Company first reported a position in CLOV in Q1 2021 and has held it in 17 quarters since. The position peaked at $2.91M in Q2 2021. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • William Blair & Company held 95,624 shares of Clover Health Investments worth $501K as of Q2 2026.
  • William Blair & Company bought 831 Clover Health Investments shares in Q2 2026, an estimated $2.82K.
  • Clover Health Investments made up ﹤0.01% of William Blair & Company's portfolio in Q2 2026, its #1231 holding.
  • William Blair & Company first reported a position in Clover Health Investments in Q1 2021 and has held it in 17 quarters since.
  • William Blair & Company's Clover Health Investments position peaked at $2.91M in Q2 2021.
  • 227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on William Blair & Company's 13F filing for Q2 2026, filed 11 Aug 2026.